0469951 - ÚOCHB 2017 RIV GB eng J - Článek v odborném periodiku
Stříšovský, Kvido
Rhomboid protease inhibitors: Emerging tools and future therapeutics.
Seminars in Cell & Developmental Biology. Roč. 60, Dec (2016), s. 52-62. ISSN 1084-9521. E-ISSN 1096-3634
Grant CEP: GA MŠMT(CZ) LK11206; GA MŠMT LO1302
GRANT EU: European Commission(XE) 304154 - Rhomboid substrates
Institucionální podpora: RVO:61388963
Klíčová slova: rhomboid protease * inhibitor * disease * mechanism * substrate specificity
Kód oboru RIV: CE - Biochemie
Impakt faktor: 6.614, rok: 2016 ; AIS: 2.465, rok: 2016
Web výsledku:
http://www.sciencedirect.com/science/article/pii/S1084952116302592DOI: https://doi.org/10.1016/j.semcdb.2016.08.021

Rhomboid-family intramembrane serine proteases are evolutionarily widespread. Their functions in different organisms are gradually being uncovered and already suggest medical relevance for infectious diseases and cancer. In contrast to these advances, selective inhibitors that could serve as efficient tools for investigation of physiological functions of rhomboids, validation of their disease relevance or as templates for drug development are lacking. In this review I extract what is known about rhomboid protease mechanism and specificity, examine the currently used inhibitors, their mechanism of action and limitations, and conclude by proposing routes for future development of rhomboid protease inhibitors.
Trvalý link: http://hdl.handle.net/11104/0268040